✦ LIBER ✦

Outcome of older patients with acute myeloid leukemia

✍ Scribed by Thein, Mya S.; Ershler, William B.; Jemal, Ahmedin; Yates, Jerome W.; Baer, Maria R.

Book ID: 120936074
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 477 KB
Volume: 119
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.28129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Geriatric assessment in older patients w

Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes

✍ Sherman, Alexander E.; Motyckova, Gabriela; Fega, K. Rebecca; DeAngelo, Daniel J 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 589 KB

Superior Long-Term Outcome With Idarubic

Superior Long-Term Outcome With Idarubicin Compared With High-Dose Daunorubicin in Patients With Acute Myeloid Leukemia Age 50 Years and Older

✍ Gardin, C.; Chevret, S.; Pautas, C.; Turlure, P.; Raffoux, E.; Thomas, X.; Quesn 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 184 KB

Attempts to Optimizing the Outcomes of A

Attempts to Optimizing the Outcomes of Allogeneic Hematopoietic Cell Transplantation in Older Patients (≥60 Years) With Acute Myeloid Leukemia and Myelodysplastic Syndrome

✍ J. Hu; J. Sykes; T. Panzarella; A. Sharma; J. Kuruvilla; J.H. Lipton; J. Wright; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 70 KB

RUNX1 Mutations Are Associated With Poor

RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

✍ Mendler, J. H.; Maharry, K.; Radmacher, M. D.; Mrozek, K.; Becker, H.; Metzeler, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 245 KB

Results of intensive chemotherapy in 998

Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome

✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

## Abstract ## BACKGROUND Elderly patients (age ≥ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s

Zosuquidar, a novel modulator of P-glyco

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

✍ Cripe, L. D.; Uno, H.; Paietta, E. M.; Litzow, M. R.; Ketterling, R. P.; Bennett 📂 Article 📅 2010 🏛 American Society of Hematology 🌐 English ⚖ 485 KB